Reuters logo
BRIEF-Celsion updates clinical data from the ovation study
May 4, 2017 / 12:29 PM / 7 months ago

BRIEF-Celsion updates clinical data from the ovation study

May 4 (Reuters) - Celsion Corp:

* Celsion updates clinical data from the ovation study in newly diagnosed advanced ovarian cancer patients

* Celsion - of five evaluable patients in first two cohorts who have been on study for over one year, only one patient’s cancer progressed after 11.7 months

* Also reported preliminary translational research findings from first four patient cohorts

* Translational research findings demonstrate that GEN-1 in ovarian cancer patients is biologically active Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below